Product Information

CARBAMAZEPINE ER 400 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.8136 per EA under NDC 68382055701. Its NADAC has been published 287 times since May 26, 2021.

FDA first approved this application on Feb 7, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CARBAMAZEPINE ER 400 MG TABLET

carbamazepine
$0.8136per EA

Strength

400 mg/1

NDC

68382055701

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CARBAMAZEPINE

Approval Type

Generic (ANDA)

FDA Application

ANDA205571

FDA Approved

2/7/2019

TE Code

AB

On Market Since

3/12/2019

Pharmacological Classes

Cytochrome P450 1A2 Inducers
Cytochrome P450 2B6 Inducers
Cytochrome P450 2C19 Inducers
Cytochrome P450 2C9 Inducers
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity
Mood Stabilizer

Price Statistics

The NADAC for CARBAMAZEPINE ER 400 MG TABLET has been published 287 times since May 26, 2021, and over the history we have for it it has declined 61.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.8136 per EA
All-time high$2.1277 (Aug 11, 2021)
All-time low$0.5156 (Nov 20, 2024)
52-week high$0.8136
52-week low$0.5655
Median price$0.9046
Average price$1.0909
Largest weekly change+78.1% (May 17, 2023)
Weeks tracked287
Tracking sinceMay 26, 2021

Price History

1W

+14.9%

1M

+24.6%

3M

+32.7%

6M

+35.4%

1Y

+11.9%

3Y

-29.3%

5Y

-60.5%

All

-61.1%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CARBAMAZEPINE ER 400 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CARBAMAZEPINE ER 400 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.8136 per EA (NDC 68382055701), effective Nov 18, 2026.

How has the price of CARBAMAZEPINE ER 400 MG TABLET changed over time?

Over the history we have for it, the NADAC for CARBAMAZEPINE ER 400 MG TABLET has declined 61.1%. It has been tracked across 287 weekly CMS publications since May 26, 2021.

What are the highest and lowest recorded NADAC prices for CARBAMAZEPINE ER 400 MG TABLET?

Since May 26, 2021, the NADAC for CARBAMAZEPINE ER 400 MG TABLET has ranged from a low of $0.5156 (Nov 20, 2024) to a high of $2.1277 (Aug 11, 2021), with a median of $0.9046 per EA.

Are there cheaper alternatives to CARBAMAZEPINE ER 400 MG TABLET?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CARBAMAZEPINE ER 400 MG TABLET, is $0.6133 per EA — about 25% below CARBAMAZEPINE ER 400 MG TABLET.

Who manufactures CARBAMAZEPINE ER 400 MG TABLET?

CARBAMAZEPINE ER 400 MG TABLET (NDC 68382055701) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.